Kostas Stamatopoulos is the Director of the Institute of Applied Biosciences at CERTH, the Center for Research and Technology Hellas, Thessaloniki, Greece. He also holds the positions of Visiting Professor in Lymphoid Tumor Biology at Uppsala University, Uppsala Sweden; and, Research Collaborator of the Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. Dr. Stamatopoulos has been involved in CLL and lymphoma research since 1994 and has published extensively about the immunobiology of lymphoid malignancies. He is Board member of ERIC, the European Research Initiative on CLL; founding member of the IMGT CLL-DB initiative and the IgCLL group, both operating under the auspices of ERIC; Board member of the Splenic Lymphoma Group; and, co-author of the Roadmap for European Hematology Research of the European Hematology Association. His current research interests include: immunogenetics of human lymphoid malignancies; cell signaling; genetic diagnostics; precision medicine in cancer; and, patient empowerment in care.